共 121 条
[1]
Haas S(1993)European consensus statement on the prevention of venous thromboembolism Blood Coagul Fibrinolysis 4 S5-8
[2]
Planès A(1998)Comparison of two low-molecular-weight heparins for the prevention of postoperative venous thromboembolism after elective hip surgery. Reviparin Study Group Blood Coagul Fibrinolysis 9 499-505
[3]
Vochelle N(1999)Is low-molecular-weight heparin the answer for the therapy of acute deep vein thrombosis? Vasc Surg 33 125-8
[4]
Fagola M(1997)Low-molecular-weight heparin: prophylaxis and treatment of venous thromboembolism Annu Rev Med 48 79-91
[5]
Vouyouka A(1998)Treatment and prevention of venous thromboembolism Semin Thromb Hemost 1 21-31
[6]
Silver D(1996)Low molecular weight heparin (reviparin) in percutaneous transluminal coronary angioplasty. Results of a randomized, double-blind, unfractionated heparin and placebo-controlled, multicenter trial (REDUCE trial) J Am Coll Cardiol 28 1437-43
[7]
Pineo GF(1998)Incidence, outcome and prediction of early clinical events following percutaneous transluminal coronary angioplasty. A comparison between treatment with reviparin and unfractionated heparin/placebo (results of a substudy of the REDUCE trial). REDUCE Study Group Eur Heart J 19 1232-8
[8]
Hull RD(1998)Low-molecular-weight heparin (reviparin) reduces the incidence of femoropopliteal in-stent stenosis: preliminary results of an ongoing study Cardiovasc Intervent Radiol 21 375-9
[9]
Hull RD(1995)Pharmacologic validation of the clinical effects of an optimized low-molecularweight heparin-reviparin Semin Thromb Hemost 21 212-27
[10]
Pineo GF(1993)Pharmacological profile of reviparin-sodium Blood Coagul Fibrinolysis 4 S11-6